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Introduction: Home enteral nutrition (HEN) is indicated in patients with a functional 
gastrointestinal tract but who are unable to meet their nutritional requirements with normally 
consumed foodstuffs. HEN allows patients to remain in their social and family environment, 
thus reducing complications and costs associated with hospital admission, while increasing 
health-related quality of life (HRQoL). HRQoL in patients with HEN is mainly evaluated by 
generic instruments, which are not sensitive enough to identify certain specific patient-related 
outcomes of HEN.
Objective: To develop a specific instrument to measure HRQoL in patients receiving HEN 
whose results allow interpretation regardless of the underlying disease and nutritional support 
administration route: the NutriQoL® questionnaire.
Materials and methods: The development of the NutriQoL entailed a literature review, 
focus groups with experts, semistructured interviews with patients, an assessment of face 
validity and feasibility, and Rasch analysis conducted on data from a sample of 141 patients 
and 24 caregivers.
Results: Of the 52 items initially proposed on the basis of the literature review, expert focus 
group, and semi-structured interviews with patients and caregivers, 17 items were finally selected 
through the development process to make up the final version of the NutriQoL, as well as a 
visual analog scale for global HRQoL scoring. The selected items were evaluated as adequate 
for frequency, importance, and clarity. Furthermore, they have been shown to be independent 
of the underlying condition and HEN administration route.
Conclusion: A new instrument for measuring the HRQoL of patients with HEN in Spain has 
been developed, whose results are independent of the underlying condition and administration 
route. The next step will be the validation of the questionnaire to ensure that the instrument 
is valid, reliable, and sensitive to health status changes in patients, to be used periodically in 
usual clinical practice.
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Introduction
Home enteral nutrition (HEN) is a feeding support technique indicated for patients who 
are unable to meet their nutritional requirements with normally consumed foodstuffs 
because of their clinical condition (patients with mechanical swallowing or transit 
disorders, neuromotor disorders, or special energy or nutrient requirements, or severely 
malnourished patients).1 The main purpose of HEN is to pass adequate nutrients through 
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the digestive tract using different administration routes 
and methods in the patient’s home.2 This intake enables 
patients to remain in their social and family environment, 
thus diminishing the likelihood of complications associated 
with hospital stay, reducing health care costs and increasing 
health-related quality of life (HRQoL).3
HRQoL is a dynamic variable in a person’s life history, 
which evaluates the subjective influence of health status, 
health care, and preventive health activities on maintaining 
a level of functioning that makes for general well-being. The 
fundamental aspects or dimensions of HRQoL are the physi-
cal, psychological/cognitive, and social functioning of the 
individual. Physical aspects include impairment of functions, 
symptoms, and pain caused by the disease or its treatment; 
psychological/cognitive aspects cover emotional states and 
intellectual functions; and social aspects reflect the person’s 
isolation, self-esteem, and social role.4
A number of studies on patients receiving HEN, designed 
to learn about HRQoL, used generic measurement instru-
ments. However, such tools are not sensitive enough to 
identify the influence of the specifics of HEN on patients.5,6 
Only one specific HRQoL questionnaire has been described 
that solely measures the impact of enteral nutrition tubes on 
patients with head and neck cancer.7
The lack of specific questionnaires to measure HRQoL 
in patients with HEN, and its impact, has highlighted the 
need to develop the NutriQoL questionnaire, a tool to assess 
HRQoL in these patients regardless of the underlying disease 
and the nutrition administration route.7
Here, we describe in detail the development of the 
NutriQoL questionnaire for measuring the HRQoL in Spanish 
patients receiving HEN regardless of the underlying condi-
tion and administration route.
Methods
study design
The NutriQoL was designed in two phases:
•	 Phase 1. Development of the specific HRQoL ques-
tionnaire for patients receiving HEN. This phase con-
sisted of a literature review, focus groups with experts, 
semistructured interviews with patients and caregivers, 
assessing face validity and feasibility, as well as the appli-
cation of Rasch analysis in a pilot study (Figure 1).
•	 Phase 2. Validation or evaluation of the psychometric 
properties of the questionnaire. During this phase, we 
tested for reliability (internal consistency, stability, 
or test–retest and interobserver agreement), sensitiv-
ity to changes, minimal clinically important difference 
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Figure 1 The nutriQol® study diagram.
Note: Phase 1 questionnaire development.
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(MCID), and validity (criterion validity and construct 
validity).
In this work, we present the questionnaire development 
methodology (Phase 1).
Different strategies were implemented in order to 
define the items to be included in the specific HRQoL 
questionnaire:
Literature review and first focus group with experts
A literature review was conducted to identify the main 
dimensions of HRQoL described in this group of patients. 
Subsequently, a focus group with seven experts with exten-
sive experience in the field of HEN was set up (one general 
practitioner, two specialists in endocrinology and nutrition, 
one specialist in geriatrics, two specialists in nutrition and 
dietetics, and one specialist in domiciliary hospitalization). 
The purpose of the focus group was to compare the experts’ 
opinions about the dimensions identified in the literature 
with respect to the HRQoL of patients with HEN and to 
determine other important aspects that were not identified 
in the literature.8
semistructured interviews with patients
Based on the conclusions of the first focus group with experts, 
a script to be used for semistructured interviews was devel-
oped, in order to learn the views of patients and caregivers, 
and determine additional issues that had not been identified 
by the experts.9
It was assumed that, given the nature of the diseases 
involved in HEN, there would be some patients who would 
not be able to complete the questionnaire on their own and 
would need the help of their caregivers. Furthermore, we 
thought it would be interesting to collect the views of the 
primary caregiver, too. Hence, for the interviews, we selected 
patients and caregivers of patients who had been receiving 
HEN for at least 3 months, regardless of the underlying 
disease. This stage enabled us to draw up a first list of items 
(version 0 of the questionnaire). All participants gave written 
informed consent to participate in the study.
second focus group with experts
Based on this list of items, we set up a second focus group 
with the same experts who had taken part in the first one 
to evaluate the items in version 0 of the questionnaire. 
This evaluation consisted of rating each of the items on 
a 5-point Likert scale (1= not clear/frequent/important 
and 5= very clear/frequent/important). Participants rated 
the clarity of the wording, the frequency of occurrence in 
routine clinical practice for each item, that is, the number 
of times it is mentioned by patients in the consulting room, 
and the importance or the degree to which the item affects 
or modifies the patient’s HRQoL from the professional’s 
perspective.10,11
For each item, we calculated the average score for each 
of the mentioned features, attaching greater value to impor-
tance and frequency, as clarity could be modified. In the 
new version of the questionnaire, we only included items 
that had the following:
•	 A high score (between 4 and 5) for clarity, frequency, 
and importance.
•	 A high score for clarity and importance despite low 
frequency.
•	 A high score for frequency and importance with modifica-
tion of the item wording (low clarity).
After this assessment of the items by the experts, we drew 
up version 1 of the questionnaire.
Face validity and feasibility
Face validity measures the degree to which the items included 
in the questionnaire seem to measure what they purport to 
measure. It is the simplest method of measuring the validity 
of the instrument. It is the common sense part of the validity 
of the questionnaire in which it is ensured that the instrument 
items are appropriate; that is, they are clear, and that their 
wording is understood. In addition, it assesses the importance 
attached to the content of the items and the appropriateness 
of the response scale used.12
Feasibility measures whether the questionnaire is acces-
sible enough to be applied in its intended field. Aspects that 
are usually evaluated are the time required for completion, 
the simplicity and harmony of the format, and the overall 
presentation of the questionnaire.12
To assess these properties, and as recommended by the 
ISPOR PRO Good Research Practices Task Force,13 we 
selected patients who had been receiving HEN for at least 
3 months, no matter what the clinical diagnosis was, and who 
were physically and intellectually able to participate in the 
interview and answer the questionnaire. Additionally, we also 
included caregivers aged $18 years. All of them consented to 
participate in the study. Participants quantitatively assessed 
aspects of the questionnaire’s face validity and feasibility, 
specifically the overall presentation of the questionnaire and 
the time spent on completing it.
As in similar studies,10 we included in the questionnaire 
the following: the items to which 90% of participants gave a 
high score (4 or 5) for importance, frequency, and clarity on 
a 5-point Likert scale (1= not important/frequent/clear and 
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5= very important/frequent/clear); items to which 90% gave 
high scores for importance and clarity even when frequency 
was not highly rated; and items to which 90% of participants 
gave high scores for frequency and importance even though 
clarity did not achieve this figure. If at least 5% and 25% of 
the participants gave negative scores (1 and 2) to the clarity 
of an item and the response scale used, respectively, both 
aspects were modified to make them easier to understand.10
As for feasibility, the overall presentation of the question-
naire was adapted when at least 10% of participants gave a 
negative score to this aspect. We considered reducing the 
number of items in the questionnaire if the average response 
time exceeded 30 minutes. Based on the results, we drew up 
version 2 of the questionnaire.
Pilot study to perform the rasch analysis
A pilot study was designed to perform the Rasch analysis.14 
We included patients .18 years who had been receiving 
HEN for at least 1 month. If patients did not comply with 
the selection criteria, the caregiver was invited to respond. 
All participants answered version 2 of the questionnaire and 
gave their consent to participate in the study. We analyzed 
the results using the Rasch model, a mathematical strategy 
used to develop and evaluate the psychometric properties of 
measurement instruments.15,16
Rasch models ensure that the characteristics of the person 
parameters and the questionnaire items are independent; that 
is, each person’s estimated ability does not depend on the 
number and type of items he/she has answered, nor does the 
difficulty of the items depend on the number and type of 
people who have answered them.17 Thus, all items work in 
the same way for all the people who complete them.18 This 
makes Rasch analysis different from the classical test theory 
(CTT), which was the most widely used measurement model 
in health sciences during the last century. In CTT, a person’s 
observed score depends on the number and difficulty of the 
items in the test. Thus, the number and particular skills of 
people influence the final score in the questionnaire.17
Next, to ensure that the remaining items were independent 
of the patient’s underlying disease and the administration 
route, that is, they could be generalized and that responses 
were not biased by any factor, we calculated differential 
item functioning (DIF). DIF occurs when people with the 
same ability have a different response probability for certain 
items according to the underlying disease or the administra-
tion route.19 One way to evaluate DIF is to perform a Rasch 
analysis on each group separately (eg, by administration 
route) and compare the estimates obtained by pairs of 
categories (eg, oral vs ostomy). A graphical representation 
of these comparisons shows the DIF items, that is, those that 
work differently in the patient group studied (outside a 95% 
confidence interval).19
Finally, we quantified the fit of the remaining items with 
the Rasch model using infit and outfit, two statistics based 
on residuals, which measure the difference between observed 
responses and those expected by the model.20 These measure-
ments ensure the adequacy of the items to measure the con-
struct of interest, in this case HRQoL, provided that the values 
are within the good fit range (-2, 2).21 With these statistics and 
their graphical representation, the items whose values were 
outside the range (-2, 2) were removed from the questionnaire 
as they did not present a good fit with the model.
After carrying out these steps, we obtained the final 
version of the NutriQoL questionnaire.
ethical aspects
This study was conducted in accordance with the principles 
of the Declaration of Helsinki while also ensuring compliance 
with the Good Clinical Practice rules. The Spanish Agency of 
Medicines and Medical Devices was notified of the study, and 
the protocol was approved by the Clinical Research Ethics 
Committee at Hospital Clinic de Barcelona.
Results
study population
Experts and different groups of patients have been involved 
in the different study phases.
Seven experts with extensive experience in the field of 
HEN were invited to participate in the two focus groups.
Twenty-one patients and ten primary caregivers took 
part in the semistructured interviews, while 19 participants 
(eleven patients and eight caregivers) responded to version 1 
of the questionnaire, to assess face validity and feasibility. 
Finally, 141 patients and 24 primary caregivers were 
recruited from eight Spanish hospitals to take part in the pilot 
study designed to perform the Rasch analysis.
Questionnaire items and scoring
During the development of the NutriQoL, the number and 
phrasing of the items were progressively modified according 
to participants’ responses and the statistical analysis.
The literature review identified the main dimensions of 
HRQoL in patients with HEN. Dimensions included char-
acteristics related to HEN (administration and intake), psy-
chological aspects and activities related to daily living, social 
life, family and employment, and working life (Table 1). 
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remained in the questionnaire, comprising version 1 of the 
NutriQoL. Finally, as a result of face validity and feasibil-
ity, three items were eliminated because of lack of clarity 
in comprehension.
Version 2 of the NutriQoL included 43 specific items 
of HEN-related HRQoL, and it had two parts: part “a” and 
part “b”. Part “a” referred to the frequency in which patients 
perceived certain situations around HEN and presented five 
response categories: Never, Sometimes, Usually, Always, 
and Does not apply to my current situation. Part “b” regarded 
the importance that patients attached to situations mentioned 
in part “a”, which included three response options: Noth-
ing important, Somehow important, and Very important. 
Additionally, a 0–100 visual analog scale, EQ-5D®-like, was 
included to evaluate patients’ overall health status.
Version 2 of the NutriQoL was used in the pilot study 
designed to perform Rasch analysis. As a result of the Rasch 
analysis, we firstly removed eleven items from the question-
naire. To ensure that the remaining 32 items were indepen-
dent of the underlying condition and administration route, 
the DIF analysis was performed, leading to the removal of 
another eleven items with DIF. Of the remaining 21 items, 
the four items whose values were outside the fit range (-2, 2) 
were removed from the questionnaire, leaving 17 items for 
the final version. A schema of the item reduction process is 
represented in Figure 1.
The 17 definitive items (Table 2) are divided into two 
dimensions: physical functioning and daily life activities 
(items 1, 5, 7, 8, 11, 18, 21, 22, 23, 27, 28, 34, 41, and 42) 
and aspects of social life (items 16, 31, and 38). These items 
can also be classified into positive (items 1–9) or negative 
(items 10–17). This classification allows for item scoring, 
as presented in Table 3. Each item is then scored by mul-
tiplying the individual scores of part “a” and part “b”. The 
total scoring of the questionnaire is given by adding up the 
scores of the individual items from a minimum of -51 to 
a maximum of +51. The patient’s HRQoL may then be 
interpreted on the basis of the overall questionnaire score 
presented in Table 4.
Discussion
HRQoL is the patient-reported health outcome variable that 
has been the focus of the greatest interest and attention in 
recent years.4 Due to the chronic nature of most underlying 
diseases of patients receiving HEN,2 measuring this vari-
able has significant value, providing information about the 
patient’s physical, psychological, and social dimensions, 
improving doctor–patient communication, facilitating shared 
Table 1 Main dimensions of hrQol in patients with hen
Dimension Characteristics
hen administration Administration frequency
Device (technology) used during 
the product administration
Product presentation
Administration route
Administration time
Product organoleptic characteristic
intake to hen nausea and vomiting
Flatulence
Diarrhea
constipation
Dyspnea (depends on the 
administration route)
insomnia
Pain
Thirst
Pyrosis
Dry mouth and throat
loss of appetite
Feeling hungry
Psychological aspects self-esteem
sleep
Body image
Depression/anxiety
Pleasure with the act of eating
Food self-sufficiency
Confidence about food 
administration skills
Activities of daily living Personal hygiene
getting dressed
housekeeping
Performing leisure activities
Performing sports activities
social life Visiting friends
relationship with strangers
Maintaining social role
Traveling
Family Family role
Dependence on relatives to eat
sexual activities
Participation in family activities
employment and working life limitations for performing
Job loss
change of job
Abbreviations: hrQol, health-related quality of life; hen, home enteral nutrition.
Experts in HEN expressed their agreement with the dimen-
sions identified, accepting that all of them were relevant and 
appropriate. As a result of the semistructured interviews, a 
set of expressions were considered relevant to the previously 
identified dimensions. These comprised the 52 items included 
in version 0 of the NutriQoL.
The second focus group with experts assessed the 
clarity of wording, frequency of occurrence, and impor-
tance of items of version 0. After evaluation, 46 items 
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decision-making, identifying and prioritizing problems, 
monitoring the impact of the disease and treatment, and in 
short, improving the quality of health care.4
However, there is little information about measuring 
HRQoL in patients receiving HEN. The few articles avail-
able mostly use generic HRQoL questionnaires that are not 
sensitive enough to assess HRQoL in these patients.6,22,23
The available questionnaires measuring nutrition-related 
HRQoL are not generalizable, irrespective of the underlying 
condition and administration route.
The Quality of Life related to Nutrition Status (CaVEN) 
questionnaire consists of 26 items that assess general health 
perception, physical activity, work activity, mood or emotional 
state, social and family relationships, and pain or discom-
fort on a score ranging from 26 (best perceived HRQoL) 
to 156 (worst perceived HRQoL).24 The reliability of the 
questionnaire is excellent, and it is easy to interpret. How-
ever, although it purports to assess the impact on HRQoL of 
interventions aimed at changing nutrition status, it does not 
evaluate specific aspects of HEN.5,6
The Home Parenteral Nutrition Quality of Life (HPN-
QOL) questionnaire consists of 48 items assessing physical, 
emotional, and symptomatic aspects, specifically in patients 
with parenteral nutrition. It contains eight functional scales 
Table 2 Questionnaire items
Item Never–sometimes–always Not important at all–important–very important
1a With hen, i can maintain my usual meal times (eg, breakfast, lunch, 
dinner, supper)
For me, maintaining my usual meal times is:
2a hen adapts to my preferences for food characteristics (eg, texture, 
color, smell, temperature, taste)
For me, the fact that hen adapts to my preferences for food 
characteristics is:
3a since i have been receiving hen, it is easier for me to move,  
and i feel more agile
For me, being able to move more easily and feeling more agile is:
4a With hen, i can continue doing my daily tasks (eg, read the 
newspaper, cook, wash the car, clean, watch TV)
For me, being able to continue doing my daily tasks is:
5a since i have been receiving hen, i perceive that my physical aspect 
is improving (eg, i see myself as healthier)
For me, perceiving that i am looking better, physically, is:
6a i can easily obtain hen preparations (eg, they are available  
in pharmacies, it is easy for me to get a prescription)
For me, being able to obtain hen preparations easily is:
7a With hen, i feel that i am well nourished For me, feeling that i am well nourished is:
8a With hen, i have gained weight For me, gaining weight is:
9b hen allows me to go out with my friends For me, being able to go out with my friends is:
10a hen harms my skin (eg, dryness, irritation, infections) For me, harming my skin is:
11a hen prevents me from sleeping well For me, sleeping well is:
12a i worry about my body adapting to hen and never being able to go 
back to feeding as before
For me, the possibility of my body adapting to hen and not 
being able to go back to feeding as before is:
13a With hen, i miss chewing and savoring food For me, chewing and savoring is:
14a With hen, i experience physical discomfort due to feeding (eg, 
feeling stomach heaviness, mouth dryness, acid reflux, regurgitation)
For me, experiencing physical discomfort due to feeding is:
15a With hen, my family keeps a closer watch over my nutrition For me, the fact that my family keeps a closer watch over  
my nutrition is:
16b With hen, i limit my activities with my friends to those not related 
to eating
For me, limiting my activities with my friends to those not 
related to eating is:
17b since i have been receiving hen, i am more concerned about  
my health
For me, being more concerned about my health is:
Notes: aPhysical functioning and activities of daily living dimension. bsocial life aspects dimension.
Abbreviation: hen, home enteral nutrition.
Table 3 Questionnaire item scoring
Type of item Scoring
Part “a” with  
positive sense
never =-1 sometimes =0 Always =1
Part “a” with  
negative sense
never =1 sometimes =0 Always =-1
Part “b” with both  
positive and negative sense
not 
important =1
somehow 
important =2
Very 
important =3
Table 4 The nutriQol® overall score and hrQol interpretation
NutriQoL® score HRQoL interpretation
Between -51 and -30 Very bad
Between -29 and -11 Bad
Between -10 and +10 regular
Between +11 and +31 good
Between +32 and +51 Very good
Abbreviation: hrQol, health-related quality of life.
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and nine symptom scales. The functional scales assess overall 
health, ability to holiday/travel, coping, physical function, 
ability to eat or drink, employment, sexual function, and 
emotional function, while the symptom scales assess body 
image, immobility, fatigue, sleep patterns, gastrointestinal 
symptoms, pain, stoma management/bowel movements, 
financial aspects, and weight. However, it does not evaluate 
the same aspects in patients receiving HEN, and therefore 
does not make it possible to reliably estimate its influence 
on the HRQoL in these patients.25
Finally, the Quality of Life in Enteral Feeding (QOL-EF) 
questionnaire is a specific instrument for assessing the 
impact of enteral nutrition tubes in patients with head and 
neck cancer.7,26 It consists of 20 items with scores between 
20 (best HRQoL) and 100 (worst HRQoL). The purpose of 
designing this questionnaire was to produce an instrument 
that would be useful in patients from different cultures, 
including Chinese people where there is a high prevalence of 
this disease. However, most of the participants included in the 
development and validation were women of Chinese origin, 
which may affect its sensitivity in aspects of other cultures 
or in male patients. Additionally, it was designed to be used 
in conjunction with other specific HRQoL questionnaires for 
patients with head and neck cancer.7 Given that this instru-
ment only measures how the enteral nutrition tube affects 
HRQoL, and that the underlying diseases and the administra-
tion route of HEN differ between patients,1 this questionnaire 
does not make it possible to study the relationship between 
HEN and HRQoL.
All this highlights the need for an instrument such as 
the NutriQoL questionnaire, a specific questionnaire to 
measure the HRQoL of patients receiving HEN, regardless 
of the underlying disease or the administration route.
To develop the NutriQoL questionnaire, we have followed 
the steps included in the US Food and Drug Administration 
guidelines,27 using an iterative process for obtaining and 
modifying items. Additionally, we used the Rasch analysis 
to reduce the number of items, ensuring that the estimates 
of the person parameters and the questionnaire items were 
independent, resolving the limitations of CTT.17
The next step in the NutriQoL development is its psycho-
metric validation to ensure validity, reliability, sensitivity to 
changes in patients’ health status, and MCID, for which a 
specific study has been designed.
Moreover, an MCID will be provided, which will facili-
tate the identification of a significant change in the patient’s 
and the clinician’s points of view during follow-up in routine 
clinical practice.28 These properties will enable clinicians to 
assess the HRQoL of patients receiving HEN and amend the 
treatment regime based on the results of their assessment.
However, we anticipate that the NutriQoL question-
naire’s sensitivity to changes will be low to moderate. This is 
because the measurements will be made over a total evaluation 
period between visits that is shorter than expected, and also 
in patients receiving HEN, where the underlying disease is 
usually a chronic problem, and observed changes in outcome 
variables are usually evident over longer periods.2,29 The ques-
tionnaire’s sensitivity to changes will have to be calculated 
again using data from patients in routine clinical practice.
In conclusion, as a result of the development of the 
NutriQoL, practitioners will have a unique and reliable tool to 
assess HRQoL in HEN patients, regardless of the underlying 
disease or the administration route.
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